Evidence map›Paper›PMID 42178542›Full record

ArticleBMC neurology2026

Temporal changes in hemoglobin-to-red blood cell distribution width ratio and its association with in-hospital all-cause mortality in patients with intracerebral hemorrhage: a retrospective analysis across MIMIC-IV and eICU databases.

Yanqun Huang, Hui Liang, Senhu Tang

Abstract read
In one paragraph

Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yanqun HuangDepartment of Medical Equipment, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, Guangxi, 530021, China. 13121391679@163.com.
Hui LiangDepartment of Neurosurgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Senhu TangDepartment of Cardiology, Liuzhou People's Hospital, Affiliated of Guangxi Medical University, Liuzhou, China.

Funding

This study was supported by the Outstanding Young Doctoral Program Research Initiation Fund of the First Affiliated Hospital of Guangxi Medical University grant 202302
6 · The paper itself

Abstract

backgroundIntracerebral hemorrhage (ICH) is associated with poor prognosis, characterized by high acute mortality and long-term disability. Real-time risk stratification using dynamic biomarkers is urgently needed to improve patient outcomes. This study aimed to explore the association between temporal changes in the hemoglobin-to-red blood cell distribution width ratio (HRR) and in-hospital all-cause mortality in patients with ICH.

methodsWe retrospectively analyzed 2,447 ICH patients from MIMIC-IV and externally validated findings in 3,142 patients from eICU. Cox regression analyzed the association between HRR (baseline and daily dynamic values) and in-hospital mortality. Restricted cubic spline (RCS) models assessed the non-linear relationship between baseline HRR and in-hospital mortality. An optimal baseline HRR cutoff for risk stratification was identified using the maximally selected log-rank statistic and subsequently externally validated. Pearson correlation analysis was applied to evaluate associations between daily HRR and in-hospital mortality, and receiver operating characteristic (ROC) curves were used to examine the time-specific predictive performance of serial HRR values.

resultsHRR exhibited a consistent inverse association with in-hospital all-cause mortality in both cohorts. In fully adjusted Cox models, continuous baseline HRR was associated with lower mortality risk (HR approximately 0.51 in both cohorts), and the highest HRR quartile was associated with a reduced mortality risk compared with the lowest quartile. Both survivors and non-survivors showed progressive HRR declines during 14-day hospitalization. Non-survivors had more pronounced declines (daily reduction approximately 0.017 vs. 0.014 in MIMIC-IV; P for trend difference < 0.001) and consistently lower HRR levels at all time points. Daily HRR was inversely correlated with mortality throughout hospitalization (adjusted HRs < 1.0, P < 0.05), with the strength of this inverse association increasing notably from Day 1 (r = -0.141) to Day 4 (r = -0.225). HRR demonstrated predictive performance comparable to Hb and RDW across time points. In the MIMIC-IV test set, all indicators presented a temporal upward trend within the initial few days, with AUCs reaching 0.631 (HRR), 0.594 (Hb) and 0.630 (RDW) at Day 1, and 0.663, 0.632 and 0.645 at Day 3, respectively. Calibration curves revealed poor predictive performance with overestimation of mortality risk. A baseline HRR cutoff of ≤ 0.74 identified high-risk patients, who had significantly higher mortality (25.14% vs. 12.93% in MIMIC-IV; 17.64% vs. 12.72% in eICU, all P < 0.001).

conclusionsThis study preliminarily suggests that temporal changes in HRR are associated with in-hospital all-cause mortality in ICH patients. HRR may serve as a complementary dynamic prognostic marker with predictive performance comparable to Hb and RDW, though its utility is limited by poor calibration. Further prospective validation in dedicated ICH cohorts with severity and imaging data is warranted, and future studies should consider underlying diseases and inflammatory status.

Indexed as

Cerebral HemorrhageErythrocyte IndicesHemoglobinsHospital MortalityAgedAged, 80 and overDatabases, FactualFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesROC CurveTime FactorsHemoglobinsDynamic changesHemoglobin-to-red blood cell distribution width ratio (HRR)In-hospital mortalityIntracerebral hemorrhage

Identifiers

PMID42178542
PMCPMC13377723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.